Aap Implantate AG annual ebitda
2021
2022
2023
2024
2025
Aap Implantate AG's calculated EBITDA was −€637,000 for fiscal 2025.
View full Aap Implantate AG company overview| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −€637,000 | €217,000 | — |
| 2024 | 2024-12-31 | −€854,000 | €2.6M | — |
| 2023 | 2023-12-31 | −€3.4M | −€1.7M | — |
| 2022 | 2022-12-31 | −€1.7M | −€948,000 | — |
| 2021 | 2021-12-31 | −€766,000 | — | — |
Between the periods ended 2021-12-31 and 2025-12-31, Aap Implantate AG's ebitda increased from −€766,000 to −€637,000, a change of €129,000.
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aap Implantate AG source filings ↗